Advertisement

Topics

After Patient Dies From Fecal Transplant, FDA Halts Trials Until Testing Improves For Drug-Resistant Bacteria

08:53 EDT 14 Jun 2019 | Kaiser Health News

The transplants have come into increasing use to treat severe intestinal orders and sometimes work quickly in patients wasting away. But the procedure to use stool from a healthy donor to restore the normal balance of bacteria and other organisms in the intestine is considered experimental by the FDA.

Original Article: After Patient Dies From Fecal Transplant, FDA Halts Trials Until Testing Improves For Drug-Resistant Bacteria

NEXT ARTICLE

More From BioPortfolio on "After Patient Dies From Fecal Transplant, FDA Halts Trials Until Testing Improves For Drug-Resistant Bacteria"

Advertisement
Quick Search
Advertisement
Advertisement